Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Recruiting 17Completed 14Terminated 8Unknown 7Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Gastrointestinal 10Tumor-Agnostic 8Thoracic 8Genitourinary 7Breast 5Dermatologic 4CNS 4Sarcoma 3Plasma cell 3Gynecologic 3Lymphoid 2Other 1Head & Neck 1Endocrine 1

Conditions

Neoplasms 7Neoplasm Metastasis 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Gemcitabine 13pembrolizumab 12Capecitabine 9Irinotecan 8Erlotinib Hydrochloride 8Carboplatin 8Blood Specimen Collection 8Nivolumab 7Docetaxel 7Cisplatin 7Cetuximab 7Paclitaxel 6Everolimus 6130-nm albumin-bound paclitaxel 6vadimezan 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cyclophosphamide 5trametinib 4Leucovorin 4Lapatinib 4Ipilimumab 4Bevacizumab 4Albumin-Bound Paclitaxel 4temsirolimus 3atezolizumab 3abemaciclib 3Trastuzumab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Terminated × Blood Specimen Collection × Tumor-Agnostic × Clear all
NCT04518072 2025-06-11

SynBioDiag

University Hospital, Montpellier

Terminated
134 enrolled
Tumor-Agnostic

Neoplasms

NCT04875871 2025-05-11

PARTICLE-PATHY

EBG MedAustron GmbH

Phase NA Terminated
13 enrolled
Tumor-Agnostic

Neoplasms

NCT05133128 2024-02-22

IMMUNOPBMC

Servier

Phase NA Terminated
36 enrolled
Tumor-Agnostic

Neoplasms

NCT02860481 2023-08-24

FRACTal

Institut Curie

Phase NA Terminated
95 enrolled
Tumor-Agnostic

Neoplasms

NCT04833075 2023-05-31

ELICIT

Radboud University Medical Center

Phase NA Terminated
19 enrolled
Tumor-Agnostic

Neoplasms

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT01855061 2018-03-09

CPCT-01

UMC Utrecht

Terminated
79 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02677311 2017-10-26

GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient

University of Kentucky

Phase NA Terminated
2 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡